ATTOVIA THERAPEUTICS, INC.

Consensus Attovia Therapeutics, Inc.

Stocks

ATTO

US04987L1026

Biotechnology & Medical Research

Market Closed - Nasdaq 01:30:00 08/10/2026 am IST			5-day change	1st Jan Change
16.42 ^USD	-6.17%		-9.58%	-

21/09	Attovia Therapeutics, Inc.(NasdaqGM:ATTO) added to S&P TMI Index	CI
16/09	Attovia Therapeutics, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 10:00 AM

Evolution of the Average Target: Attovia Therapeutics, Inc.

Evolution of the Average Target - Attovia Therapeutics, Inc.

Evolution of the Target Price: Attovia Therapeutics, Inc.

Evolution of the Target Price - Attovia Therapeutics, Inc.

Changes in Analyst Recommendations: Attovia Therapeutics, Inc.

6c27059ee4bbbb73.D_L6bN83f5DYXnfIDq5acgQjU_lgY_wg-EzJfLt3uOw.bMueHYlTT_eqHD2gf8Y9RjRtOLs5EZVZoiKiL4wDjd5pxYkPj1M4x5MZQw~033db840e11a7f187328484d3c102f79

Analysts' recommendations: Attovia Therapeutics, Inc.

31/08	Attovia Therapeutics Could Serve as Key Player in Immunology, Inflammation, RBC Says	MT
31/08	Morgan Stanley Initiates Coverage on Attovia Therapeutics With Overweight Rating	MT
31/08	Leerink Partners Initiates Attovia Therapeutics at Outperform With $52 Price Target	MT
31/08	RBC Initiates Attovia Therapeutics at Outperform, Speculative Risk With $45 Price Target	MT
31/08	Citigroup Initiates Attovia Therapeutics at Buy With $30 Price Target	MT

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ATTOVIA THERAPEUTICS, INC.	-	-			+141.14%
	WUXI APPTEC CO., LTD.					+13.99%
	ARGENX SE					+24.38%
	LONZA GROUP AG					+19.43%
	REVOLUTION MEDICINES, INC.					+29.48%
	IQVIA HOLDINGS INC.					+11.87%
	BEONE MEDICINES AG					+19.5%
	CELLTRION, INC.					+46.79%
	WUXI BIOLOGICS (CAYMAN) INC.					+0.6%
	BIONTECH SE					+21.55%
	Average					+32.87%
	Weighted average by Cap.					+20.51%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

5

Last Close Price

17.50USD

Average target price

42.20USD

Spread / Average Target

+141.14%

High Price Target

52.00USD

Spread / Highest target

+197.14%

Low Price Target

30.00USD

Spread / Lowest Target

+71.43%

Analyst Consensus Detail

Analyst consensus - Attovia Therapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Attovia Therapeutics, Inc.

Stock Market
Stocks
ATTO Stock
Consensus Attovia Therapeutics, Inc.

The best tools reserved for subscribers to boost the performance of your investments!